HCC Stock Recent News

Warrior Met Coal's Blue Creek project could double production by 2030, but heavy CAPEX and market volatility pose significant risks. The coal market's dependence on China's steel industry and India's growing demand are critical factors for Warrior's future performance. Despite strong cash flow generation, Warrior's increased share issuance and investment needs for Blue Creek may strain finances if market conditions worsen.

BROOKWOOD, Ala.--(BUSINESS WIRE)--Warrior Met Coal, Inc. (NYSE:HCC) (“Warrior” or the “Company”) today announced that its board of directors has approved a regular quarterly cash dividend of $0.08 per share to be paid on March 3, 2025, to stockholders of record as of the close of business on February 24, 2025. About Warrior Warrior is a U.S.-based, environmentally, and socially minded supplier to the global steel industry. It is dedicated entirely to mining non-thermal metallurgical (met) coal.

BROOKWOOD, Ala.--(BUSINESS WIRE)--Warrior Met Coal, Inc. (NYSE: HCC) (“Warrior” or the “Company”) today announced the recent publication of its 2024 sustainability report, now available on the Company's website at www.warriormetcoal.com/sustainability. The report details Warrior's commitment to sustainability principles. The report's highlights include: 19% improvement in safety incidence rate compared to 2023, Total incidence rate 65% lower than the national average for underground coal mines.

Despite the expected drop in U.S. coal production volumes, Zacks Coal industry players like BTU, HCC, SXC and METC are likely to remain competitive in the coal space.

BROOKWOOD, Ala.--(BUSINESS WIRE)--Warrior Met Coal, Inc. (“Warrior” or NYSE: HCC) today announced that it will hold its fourth quarter 2024 investor conference call at 4:30 p.m. ET on Thursday, February 13, 2025. Warrior will release its results following the close of market trading that afternoon. To participate in the conference call, please call 1-844-340-9047 (domestic) or 1-412-858-5206 (international) 10 minutes prior to the start time and reference the Warrior Met Coal conference call. A.

Top 6 Businesses We Own: Q4 2024 Update

Warrior Met Coal: Characterized By Low Operating Expenses And Solid Capital Deployment

BRISBANE, Calif., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class1 targeted and immune-mediated therapeutics to fight cancer, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to amezalpat (TPST-1120), an oral, small molecule, selective PPAR⍺ antagonist for the treatment of patients with hepatocellular carcinoma (HCC).

Warrior Met Coal focuses on exporting metallurgical coal from Alabama, with strong production capabilities and a promising Blue Creek project expected to boost output in 2026. Q2 2024 results showed declines in EBITDA and net income due to weak coking coal prices, but Warrior maintains a robust balance sheet with $709M in cash. Despite lower shareholder returns and no recent buybacks, Blue Creek's future production and cost benefits present a significant upside for long-term investors.

Warrior Met Coal, Inc. (NYSE:HCC ) Q2 2024 Results Earnings Conference Call August 2, 2024 4:30 PM ET Company Participants D'Andre Wright - Vice President, External Affairs Walter Scheller, III - Chief Executive Officer Dale Boyles - Chief Financial Officer Conference Call Participants Lucas Pipes - B. Riley Securities Nathan Martin - The Benchmark Company Katja Jancic - BMO Capital Markets Operator Good afternoon.